Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laura Hetzel"'
Autor:
Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Ssebyatika, Verena Krähling, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bošnjak, Swantje I. Hammerschmidt, Reinhold Förster
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Vaccines against SARS-CoV-2 have changed the course of the COVID-19 pandemics, but waning immunity necessitates repeated immunization. Authors here show that immunity declines faster following two doses of vector-based vaccine compared to a first dos
Externí odkaz:
https://doaj.org/article/f52b7c9a5c1744e8b2ee862e712fdd80
Autor:
Joana Barros-Martins, Swantje I. Hammerschmidt, Gema Morillas Ramos, Anne Cossmann, Laura Hetzel, Ivan Odak, Miriam Köhler, Metodi V. Stankov, Christiane Ritter, Michaela Friedrichsen, Inga Ravens, Anja Schimrock, Jasmin Ristenpart, Anika Janssen, Stefanie Willenzon, Günter Bernhardt, Ralf Lichtinghagen, Berislav Bošnjak, Georg M. N. Behrens, Reinhold Förster
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Since early 2022, various Omicron variants have dominated the SARS-CoV-2 pandemic in most countries. All Omicron variants are B-cell immune escape variants, and antibodies induced by first-generation COVID-19 vaccines or by infection with earlier SAR
Externí odkaz:
https://doaj.org/article/11b381854c5e4bc19005652544e278a1
Autor:
Georg Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Ssebyatika, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bosnjak, Swantje Hammerschmidt, Reinhold Forster
Reports suggest that COVID-19 vaccine effectiveness is decreasing, either due to waning immune protection, emergence of new variants of concern, or both. Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19, ChAd) follow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad91bb62b86b014c0c6a466fcc67901
https://doi.org/10.21203/rs.3.rs-1200506/v1
https://doi.org/10.21203/rs.3.rs-1200506/v1
Autor:
Georg M. N. Behrens, Joana Barros-Martins, Anne Cossmann, Gema Morillas Ramos, Metodi V. Stankov, Ivan Odak, Alexandra Dopfer-Jablonka, Laura Hetzel, Miriam Köhler, Gwendolyn Patzer, Christoph Binz, Christiane Ritter, Michaela Friedrichsen, Christian Schultze-Florey, Inga Ravens, Stefanie Willenzon, Anja Bubke, Jasmin Ristenpart, Anika Janssen, George Ssebyatika, Verena Krähling, Günter Bernhardt, Markus Hoffmann, Stefan Pöhlmann, Thomas Krey, Berislav Bošnjak, Swantje I. Hammerschmidt, Reinhold Förster
Publikováno v:
Nature communications. 13(1)
Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19, ChAd) followed by an mRNA vaccine (e.g. BNT162b2, BNT) has been reported to be superior in inducing protective immunity compared to repeated application of the same v